Next year’s codeine behaviour forecast

tired woman: multiple sclerosis illustration
New figures show many will still see pharmacy as their first port of call for pain relief after codeine is upscheduled New research from Sanofi Consumer Healthcare investigated the likely impact of the upcoming regulatory changes, following the TGA’s decision to upschedule low-dose codeine to prescription only. A significant number— 45%—will still head straight to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous A changing climate
Next Travel for your education